DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD OF 3, 4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE IN DRIED BLOOD SPOT USING GAS CHROMATOGRAPHY-MASS SPEC-TROMETRY

  • YAHDIANA HARAHAP Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, Indonesia
  • HANZEL IRAWAN Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, Indonesia
  • KUSWARDANI Badan Narkotika Nasional (Indonesian National Narcotics Agency), Cigombong 16110, West Java, Indonesia

Abstract

Objective: This study aims to develop and validate the analytical method to determine 3,4-Methylenedioxy-N-ethylamphetamine (MDEA) in DBS using GC-MS.


Methods: This research used liquid-liquid micro-extraction for sample preparation and analysis was performed by GC-MS. In the method development, the optimized parameters were flow rate, column temperature, the spot of blood volume, % haematocrit, extraction and reconstitution of solvent volume, and sonication duration. Validation of the chosen method was performed based on EMEA bioanalytical guideline in 2011.


Results: The optimum chromatographic conditions were obtained using HP-5 MS capillary columns (30 m x 0.25 mm i.d; 0.25 μm ); helium with 99.9% purity as a mobile phase; flow rate of 1.0 ml/min; column temperature was 250 °C; MS detection using 4 fragments at m/z values ​​of 72.00 and 44.00 for MDEA and 58.00 and 77.00 for ephedrine HCl as an internal standard. The DBS paper with the volume of blood spot 40 μl was then extracted using liquid-liquid micro-extraction with methanol 700 μl, sonication for 5 min, evaporated with nitrogen gas then reconstituted with 50 μl ethyl acetate. The validation results fulfilled the requirements based on the EMEA bioanalytical guideline in 2011.


Conclusion: It can be concluded that the optimum condition of the analytical method by using GC-MS was obtained and fulfilled validation criteria with a range concentration of 15-250 ng/ml.

Keywords: DBS, Ephedrine HCl, GC-MS, Liquid-liquid microextraction, MDEA, Validation

References

1. United Nations Office on Drugs and Crime (UNODC). World Drug Report. Vienna: United Nations; 2017.
2. Ruzilawati A, Miran H. Validated high-performance liquid chromatography method for analysis of methamphetamine in human urine using liquid-liquid extraction. Asian Journal Of Pharmaceutical And Clinical Research 2015;8:199-201.
3. Ministry of Health of the Republic of Indonesia. Law of the Republic of Indonesia Number 35 of 2009 concerning Nar-cotics. Jakarta; 2009.
4. Dettmeyer R, Verhoff M, Schu?tz H. Forensic medicine: fun-damentals and perspectives. Springer; 2014.
5. Lessenger J, Roper G. Drug courts-a new approach to treat-ment and rehabilitation. New York: Springer Science; 2007.
6. Sadones N, Capiau S, De Kesel P, Lambert W, Stove C. Spot them in the spot: analysis of abused substances using dried blood spots. Bioanalysis 2014;6:2211-27.
7. Chapman K, Burnett J, Corvaro M, Mitchell D, Robinson S, Sangster T, et al. Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite. Bioanalysis 2014;6:2965-8.
8. Majors R. sample preparation fundamentals for chromatog-raphy. Santa Clara: Agilent Technologies; 2013.
9. Dahal R, Moriam K, Seppala P. Downstream process: liquid-liquid extraction. AALTO University School of Chemical Technology; 2016.
10. Abdel Rehim M. Microextraction by packed sorbent (MEPS): a tutorial. Anal Chim Acta 2011;70:119-28.
11. Pedersen Bjergaard S, Rasmussen K. Liquid-phase microex-traction with porous hollow fibers, a miniaturized and highly flexible format for liquid–liquid extraction. Journal of Chromatography A 2008;1184:132-42.
12. Harahap Y, Hakim M, Soedigdo K. Development and validation of metamphetamine analysis in saliva using gas chro-matography-tandem mass spectrometry. Int J Appl Pharm 2018;97:98-101.
13. Miller J. Chromatography, Hoboken, New Jersey: John Wiley; 2009. p. 309-29.
14. European Medicines Agency. EMEA, Guideline on Bioanalytical Method Validation, Science Medicines Health. London: An Agency of the European Union; 2011.
15. Freudenmann R, Spitzer M. The neuropsychopharmacology and toxicology of 3,4-methylenedioxy-n-ethyl-amphetamine (MDEA). CNS Drug Rev 2006;10:89-116.
16. Ambach L, Hernandez Redondo A, Konig S, Weinmann W. Rapid and simple LC-MS/MS screening of 64 novel psychoactive sub-stances using dried blood spots. Drug Testing Anal 2013;6:367-75.
17. Lin Z, Li J, Zhang X, Qiu M, Huang Z, Rao Y. Ultrasound-assisted dispersive liquid-liquid microextraction for the determination of seven recreational drugs in human whole blood using gas chromatography-mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 2017;1046:177-84.
18. Westphal F, Franzelius C, Schafer J, Schutz H, Rochholz G. Development of a validated method for the simultaneous determination of amphetamine, methamphetamine and methylenedioxyamphetamines (MDA, MDMA, MDEA) in serum by GC-MS after derivatisation with perfluorooctanoyl chlo-ride. Accredit Qual Assur 2007;12:335-42.
19. Halket J, Waterman D, Przyborowska A, Patel R, Fraser P, Bramley P. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Botany 2004;56:219-43.
20. Lin D, Wang S, Wu C, Chen B, Liu R. Chemical derivatization for the analysis of drugs by gc-ms-a conceptual review. J Food Drug Anal 2008;16:1-10.
Statistics
70 Views | 39 Downloads
Citatons
How to Cite
HARAHAP, Y., IRAWAN, H., & KUSWARDANI. (2020). DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD OF 3, 4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE IN DRIED BLOOD SPOT USING GAS CHROMATOGRAPHY-MASS SPEC-TROMETRY. International Journal of Applied Pharmaceutics, 12(4), 94-99. https://doi.org/10.22159/ijap.2020v12i4.32304
Section
Original Article(s)